There is clear evidence for the complex process of neoangiogenic signals, the failures of anti-VEGFA treatments in UMs, the binding affinity of VEGF to hematopoietic or neural stem cells, and the presence of CSCs in circulating or metastatic UM tumors. Here, VEGFA is linked to ulnar-mammary syndrome.